WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca Pharmaceuticals LP (NYSE: AZN) and HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc. (NYSE: WLP), today announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease.
